aluates Reports

$ 0.0

Automative

Global Injection Peptide Drug Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-8J10732

Global Injection Peptide Drug Market Research Report 2022

BUY CHAPTERS

Global Injection Peptide Drug Market Research Report 2025

Code: QYRE-Auto-8J10732

Report

February 2025

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

TEVA

Novo Nordisk

Takeda

Eli Lilly

Astrazeneca plc

Novartis

AbbVie

Ipsen S A

Ferring

Merck

The Medicines

J & J

Injection Peptide Drug Market Size

The global market for Injection Peptide Drug was valued at US$ 40090 million in the year 2024 and is projected to reach a revised size of US$ 72680 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Injection Peptide Drug Market

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.

This report aims to provide a comprehensive presentation of the global market for Injection Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Peptide Drug.

The Injection Peptide Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injection Peptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injection Peptide Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Injection Peptide Drug Market Report

Report Metric	Details
Report Name	Injection Peptide Drug Market
Accounted market size in year	US$ 40090 million
Forecasted market size in 2031	US$ 72680 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Intravenous Injection Subcutaneous Injection
Segment by Application	Cancer Metabolic Disorders Central Nervous System Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, J & J
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injection Peptide Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Injection Peptide Drug Market growing?

Ans: The Injection Peptide Drug Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Injection Peptide Drug Market size in 2031?

Ans: The Injection Peptide Drug Market size in 2031 will be US$ 72680 million.

Who are the main players in the Injection Peptide Drug Market report?

Ans: The main players in the Injection Peptide Drug Market are Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, J & J

What are the Application segmentation covered in the Injection Peptide Drug Market report?

Ans: The Applications covered in the Injection Peptide Drug Market report are Cancer, Metabolic Disorders, Central Nervous System, Other

What are the Type segmentation covered in the Injection Peptide Drug Market report?

Ans: The Types covered in the Injection Peptide Drug Market report are Intravenous Injection, Subcutaneous Injection

Recommended Reports

Peptide Drug Markets

Injectable Drug Delivery

Amino Acid & Protein

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Injection Peptide Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Intravenous Injection

1.2.3 Subcutaneous Injection

1.3 Market by Application

1.3.1 Global Injection Peptide Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Metabolic Disorders

1.3.4 Central Nervous System

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Injection Peptide Drug Market Perspective (2020-2031)

2.2 Global Injection Peptide Drug Growth Trends by Region

2.2.1 Global Injection Peptide Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Injection Peptide Drug Historic Market Size by Region (2020-2025)

2.2.3 Injection Peptide Drug Forecasted Market Size by Region (2026-2031)

2.3 Injection Peptide Drug Market Dynamics

2.3.1 Injection Peptide Drug Industry Trends

2.3.2 Injection Peptide Drug Market Drivers

2.3.3 Injection Peptide Drug Market Challenges

2.3.4 Injection Peptide Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Injection Peptide Drug Players by Revenue

3.1.1 Global Top Injection Peptide Drug Players by Revenue (2020-2025)

3.1.2 Global Injection Peptide Drug Revenue Market Share by Players (2020-2025)

3.2 Global Injection Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Injection Peptide Drug Revenue

3.4 Global Injection Peptide Drug Market Concentration Ratio

3.4.1 Global Injection Peptide Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Injection Peptide Drug Revenue in 2024

3.5 Global Key Players of Injection Peptide Drug Head office and Area Served

3.6 Global Key Players of Injection Peptide Drug, Product and Application

3.7 Global Key Players of Injection Peptide Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Injection Peptide Drug Breakdown Data by Type

4.1 Global Injection Peptide Drug Historic Market Size by Type (2020-2025)

4.2 Global Injection Peptide Drug Forecasted Market Size by Type (2026-2031)

5 Injection Peptide Drug Breakdown Data by Application

5.1 Global Injection Peptide Drug Historic Market Size by Application (2020-2025)

5.2 Global Injection Peptide Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Injection Peptide Drug Market Size (2020-2031)

6.2 North America Injection Peptide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Injection Peptide Drug Market Size by Country (2020-2025)

6.4 North America Injection Peptide Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Injection Peptide Drug Market Size (2020-2031)

7.2 Europe Injection Peptide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Injection Peptide Drug Market Size by Country (2020-2025)

7.4 Europe Injection Peptide Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Injection Peptide Drug Market Size (2020-2031)

8.2 Asia-Pacific Injection Peptide Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Injection Peptide Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Injection Peptide Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Injection Peptide Drug Market Size (2020-2031)

9.2 Latin America Injection Peptide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Injection Peptide Drug Market Size by Country (2020-2025)

9.4 Latin America Injection Peptide Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Injection Peptide Drug Market Size (2020-2031)

10.2 Middle East & Africa Injection Peptide Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Injection Peptide Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Injection Peptide Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Injection Peptide Drug Introduction

11.1.4 Sanofi Revenue in Injection Peptide Drug Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Injection Peptide Drug Introduction

11.2.4 Teva Revenue in Injection Peptide Drug Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Injection Peptide Drug Introduction

11.3.4 Novo Nordisk Revenue in Injection Peptide Drug Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Injection Peptide Drug Introduction

11.4.4 Takeda Revenue in Injection Peptide Drug Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Injection Peptide Drug Introduction

11.5.4 Eli Lilly Revenue in Injection Peptide Drug Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Injection Peptide Drug Introduction

11.6.4 AstraZeneca Revenue in Injection Peptide Drug Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Injection Peptide Drug Introduction

11.7.4 Novartis Revenue in Injection Peptide Drug Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Injection Peptide Drug Introduction

11.8.4 AbbVie Revenue in Injection Peptide Drug Business (2020-2025)

11.8.5 AbbVie Recent Development

11.9 Ipsen

11.9.1 Ipsen Company Details

11.9.2 Ipsen Business Overview

11.9.3 Ipsen Injection Peptide Drug Introduction

11.9.4 Ipsen Revenue in Injection Peptide Drug Business (2020-2025)

11.9.5 Ipsen Recent Development

11.10 Ferring

11.10.1 Ferring Company Details

11.10.2 Ferring Business Overview

11.10.3 Ferring Injection Peptide Drug Introduction

11.10.4 Ferring Revenue in Injection Peptide Drug Business (2020-2025)

11.10.5 Ferring Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Injection Peptide Drug Introduction

11.11.4 Merck Revenue in Injection Peptide Drug Business (2020-2025)

11.11.5 Merck Recent Development

11.12 The Medicines

11.12.1 The Medicines Company Details

11.12.2 The Medicines Business Overview

11.12.3 The Medicines Injection Peptide Drug Introduction

11.12.4 The Medicines Revenue in Injection Peptide Drug Business (2020-2025)

11.12.5 The Medicines Recent Development

11.13 J & J

11.13.1 J & J Company Details

11.13.2 J & J Business Overview

11.13.3 J & J Injection Peptide Drug Introduction

11.13.4 J & J Revenue in Injection Peptide Drug Business (2020-2025)

11.13.5 J & J Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

TEVA

Novo Nordisk

Takeda

Eli Lilly

Astrazeneca plc

Novartis

AbbVie

Ipsen S A

Ferring

Merck

The Medicines

J & J

List of Tables

Table 1. Global Injection Peptide Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Intravenous Injection

Table 3. Key Players of Subcutaneous Injection

Table 4. Global Injection Peptide Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Injection Peptide Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Injection Peptide Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Injection Peptide Drug Market Share by Region (2020-2025)

Table 8. Global Injection Peptide Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Injection Peptide Drug Market Share by Region (2026-2031)

Table 10. Injection Peptide Drug Market Trends

Table 11. Injection Peptide Drug Market Drivers

Table 12. Injection Peptide Drug Market Challenges

Table 13. Injection Peptide Drug Market Restraints

Table 14. Global Injection Peptide Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Injection Peptide Drug Market Share by Players (2020-2025)

Table 16. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2024)

Table 17. Ranking of Global Top Injection Peptide Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Injection Peptide Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Injection Peptide Drug, Headquarters and Area Served

Table 20. Global Key Players of Injection Peptide Drug, Product and Application

Table 21. Global Key Players of Injection Peptide Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Injection Peptide Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Injection Peptide Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Injection Peptide Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Injection Peptide Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Injection Peptide Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Injection Peptide Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Injection Peptide Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Injection Peptide Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Injection Peptide Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Injection Peptide Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Injection Peptide Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Injection Peptide Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Injection Peptide Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Injection Peptide Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Injection Peptide Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Injection Peptide Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Injection Peptide Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Injection Peptide Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Injection Peptide Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sanofi Company Details

Table 47. Sanofi Business Overview

Table 48. Sanofi Injection Peptide Drug Product

Table 49. Sanofi Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 50. Sanofi Recent Development

Table 51. Teva Company Details

Table 52. Teva Business Overview

Table 53. Teva Injection Peptide Drug Product

Table 54. Teva Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 55. Teva Recent Development

Table 56. Novo Nordisk Company Details

Table 57. Novo Nordisk Business Overview

Table 58. Novo Nordisk Injection Peptide Drug Product

Table 59. Novo Nordisk Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 60. Novo Nordisk Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda Injection Peptide Drug Product

Table 64. Takeda Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Eli Lilly Company Details

Table 67. Eli Lilly Business Overview

Table 68. Eli Lilly Injection Peptide Drug Product

Table 69. Eli Lilly Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 70. Eli Lilly Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Injection Peptide Drug Product

Table 74. AstraZeneca Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Injection Peptide Drug Product

Table 79. Novartis Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. AbbVie Company Details

Table 82. AbbVie Business Overview

Table 83. AbbVie Injection Peptide Drug Product

Table 84. AbbVie Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 85. AbbVie Recent Development

Table 86. Ipsen Company Details

Table 87. Ipsen Business Overview

Table 88. Ipsen Injection Peptide Drug Product

Table 89. Ipsen Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 90. Ipsen Recent Development

Table 91. Ferring Company Details

Table 92. Ferring Business Overview

Table 93. Ferring Injection Peptide Drug Product

Table 94. Ferring Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 95. Ferring Recent Development

Table 96. Merck Company Details

Table 97. Merck Business Overview

Table 98. Merck Injection Peptide Drug Product

Table 99. Merck Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 100. Merck Recent Development

Table 101. The Medicines Company Details

Table 102. The Medicines Business Overview

Table 103. The Medicines Injection Peptide Drug Product

Table 104. The Medicines Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 105. The Medicines Recent Development

Table 106. J & J Company Details

Table 107. J & J Business Overview

Table 108. J & J Injection Peptide Drug Product

Table 109. J & J Revenue in Injection Peptide Drug Business (2020-2025) & (US$ Million)

Table 110. J & J Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Injection Peptide Drug Picture

Figure 2. Global Injection Peptide Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Injection Peptide Drug Market Share by Type: 2024 VS 2031

Figure 4. Intravenous Injection Features

Figure 5. Subcutaneous Injection Features

Figure 6. Global Injection Peptide Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Injection Peptide Drug Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Metabolic Disorders Case Studies

Figure 10. Central Nervous System Case Studies

Figure 11. Other Case Studies

Figure 12. Injection Peptide Drug Report Years Considered

Figure 13. Global Injection Peptide Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Injection Peptide Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Injection Peptide Drug Market Share by Region: 2024 VS 2031

Figure 16. Global Injection Peptide Drug Market Share by Players in 2024

Figure 17. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Injection Peptide Drug Revenue in 2024

Figure 19. North America Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Injection Peptide Drug Market Share by Country (2020-2031)

Figure 21. United States Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Injection Peptide Drug Market Share by Country (2020-2031)

Figure 25. Germany Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Injection Peptide Drug Market Share by Region (2020-2031)

Figure 33. China Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Injection Peptide Drug Market Share by Country (2020-2031)

Figure 41. Mexico Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Injection Peptide Drug Market Share by Country (2020-2031)

Figure 45. Turkey Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Injection Peptide Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Sanofi Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 49. Teva Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 50. Novo Nordisk Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 51. Takeda Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 52. Eli Lilly Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 55. AbbVie Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 56. Ipsen Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 57. Ferring Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 58. Merck Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 59. The Medicines Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 60. J & J Revenue Growth Rate in Injection Peptide Drug Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Peptide Drugs Market Research Report 2024

Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Antibiotics Sterile Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Global Peptide Synthesis Service Market Insights Forecast to 2030

Proteins Amino Acids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Synthesis Reagent Market Research Report 2024

Global Chemical Synthesis Peptide Drugs Market Research Report 2024

Global Peptide Building Block Market Insights Forecast to 2030

Global Clinical Peptide Market Research Report 2024

Global CMO Peptide Market Research Report 2025

Global Peptide Synthesis Market Insights Forecast to 2030

Global Peptide Drug Condensation Reagents Market Research Report 2025

Peptide Coupling Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Amino Acids Market Research Report 2025

Global Peptide Synthesis CMO Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions